186 related articles for article (PubMed ID: 29936069)
21. Mammalian short palate lung and nasal epithelial clone 1 (SPLUNC1) in pH-dependent airway hydration.
Tarran R; Redinbo MR
Int J Biochem Cell Biol; 2014 Jul; 52():130-5. PubMed ID: 24631954
[TBL] [Abstract][Full Text] [Related]
22. SPLUNC1 expression reduces surface levels of the epithelial sodium channel (ENaC) in Xenopus laevis oocytes.
Rollins BM; Garcia-Caballero A; Stutts MJ; Tarran R
Channels (Austin); 2010; 4(4):255-9. PubMed ID: 20519934
[TBL] [Abstract][Full Text] [Related]
23. Inhaled ENaC antisense oligonucleotide ameliorates cystic fibrosis-like lung disease in mice.
Crosby JR; Zhao C; Jiang C; Bai D; Katz M; Greenlee S; Kawabe H; McCaleb M; Rotin D; Guo S; Monia BP
J Cyst Fibros; 2017 Nov; 16(6):671-680. PubMed ID: 28539224
[TBL] [Abstract][Full Text] [Related]
24. The epithelial sodium channel (ENaC) as a therapeutic target for cystic fibrosis.
Shei RJ; Peabody JE; Kaza N; Rowe SM
Curr Opin Pharmacol; 2018 Dec; 43():152-165. PubMed ID: 30340955
[TBL] [Abstract][Full Text] [Related]
25. Human neutrophil elastase degrades SPLUNC1 and impairs airway epithelial defense against bacteria.
Jiang D; Wenzel SE; Wu Q; Bowler RP; Schnell C; Chu HW
PLoS One; 2013; 8(5):e64689. PubMed ID: 23741370
[TBL] [Abstract][Full Text] [Related]
26. Sputum trypsin-like protease activity relates to clinical outcome in cystic fibrosis.
Reihill J; Moffitt K; Douglas L; Stuart Elborn J; Jones A; Lorraine Martin S
J Cyst Fibros; 2020 Jul; 19(4):647-653. PubMed ID: 31932105
[TBL] [Abstract][Full Text] [Related]
27. SPLUNC1: a novel marker of cystic fibrosis exacerbations.
Khanal S; Webster M; Niu N; Zielonka J; Nunez M; Chupp G; Slade MD; Cohn L; Sauler M; Gomez JL; Tarran R; Sharma L; Dela Cruz CS; Egan M; Laguna T; Britto CJ
Eur Respir J; 2021 Nov; 58(5):. PubMed ID: 33958427
[TBL] [Abstract][Full Text] [Related]
28. Preclinical evaluation of the epithelial sodium channel inhibitor AZD5634 and implications on human translation.
Åstrand A; Libby EF; Shei RJ; Lever JEP; Kaza N; Adewale AT; Boitet E; Edwards L; Hemmerling M; Root J; Lindberg B; Wingren C; Malmgren A; Sabater J; Rowe SM
Am J Physiol Lung Cell Mol Physiol; 2022 Nov; 323(5):L536-L547. PubMed ID: 36098422
[TBL] [Abstract][Full Text] [Related]
29. Therapeutic Effects of α1-Antitrypsin on Psedumonas aeruginosa Infection in ENaC Transgenic Mice.
Nichols DP; Jiang D; Happoldt C; Berman R; Chu HW
PLoS One; 2015; 10(10):e0141232. PubMed ID: 26509529
[TBL] [Abstract][Full Text] [Related]
30. ENaC inhibitors for the treatment of cystic fibrosis.
Butler R; Hunt T; Smith NJ
Pharm Pat Anal; 2015 Jan; 4(1):17-27. PubMed ID: 25565157
[TBL] [Abstract][Full Text] [Related]
31. Automated acquisition and analysis of airway surface liquid height by confocal microscopy.
Choi HC; Kim CS; Tarran R
Am J Physiol Lung Cell Mol Physiol; 2015 Jul; 309(2):L109-18. PubMed ID: 26001773
[TBL] [Abstract][Full Text] [Related]
32. Non-genomic estrogen regulation of ion transport and airway surface liquid dynamics in cystic fibrosis bronchial epithelium.
Saint-Criq V; Kim SH; Katzenellenbogen JA; Harvey BJ
PLoS One; 2013; 8(11):e78593. PubMed ID: 24223826
[TBL] [Abstract][Full Text] [Related]
33. Nonclinical safety assessment of SPX-101, a novel peptide promoter of epithelial sodium channel internalization for the treatment of cystic fibrosis.
Walker MP; Cowlen M; Christensen D; Miyamoto M; Barley P; Crowder T
Inhal Toxicol; 2017 Jul; 29(8):356-365. PubMed ID: 28984146
[TBL] [Abstract][Full Text] [Related]
34. Cigarette smoke modifies and inactivates SPLUNC1, leading to airway dehydration.
Moore PJ; Reidel B; Ghosh A; Sesma J; Kesimer M; Tarran R
FASEB J; 2018 Jun; 32(12):fj201800345R. PubMed ID: 29890087
[TBL] [Abstract][Full Text] [Related]
35. High-mobility group box-1 increases epithelial sodium channel activity and inflammation via the receptor for advanced glycation end products.
Grant GJ; Liou TG; Paine R; Helms MN
Am J Physiol Cell Physiol; 2020 Mar; 318(3):C570-C580. PubMed ID: 31913693
[TBL] [Abstract][Full Text] [Related]
36. Expression and function of Anoctamin 1/TMEM16A calcium-activated chloride channels in airways of in vivo mouse models for cystic fibrosis research.
Hahn A; Salomon JJ; Leitz D; Feigenbutz D; Korsch L; Lisewski I; Schrimpf K; Millar-Büchner P; Mall MA; Frings S; Möhrlen F
Pflugers Arch; 2018 Sep; 470(9):1335-1348. PubMed ID: 29860639
[TBL] [Abstract][Full Text] [Related]
37. Short Palate, Lung, and Nasal Epithelial Clone 1 Has Antimicrobial and Antibiofilm Activities against the Burkholderia cepacia Complex.
Ahmad S; Tyrrell J; Walton WG; Tripathy A; Redinbo MR; Tarran R
Antimicrob Agents Chemother; 2016 Oct; 60(10):6003-12. PubMed ID: 27458217
[TBL] [Abstract][Full Text] [Related]
38. Epithelial Na
Smith NJ; Solovay CF
Pharm Pat Anal; 2017 Jul; 6(4):179-188. PubMed ID: 28696180
[TBL] [Abstract][Full Text] [Related]
39. Pharmacotherapy of the ion transport defect in cystic fibrosis: role of purinergic receptor agonists and other potential therapeutics.
Kunzelmann K; Mall M
Am J Respir Med; 2003; 2(4):299-309. PubMed ID: 14719996
[TBL] [Abstract][Full Text] [Related]
40. The Multifunctional Roles of Short Palate, Lung, and Nasal Epithelium Clone 1 in Regulating Airway Surface Liquid and Participating in Airway Host Defense.
Liu Q; Wang Z; Zhang W
J Interferon Cytokine Res; 2021 Apr; 41(4):139-148. PubMed ID: 33885339
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
